Tag Archives: United States

Making Sense of US Health Reform: Some Points for the Perplexed

The March 21 passage by Congress of the Patient Protection and Affordable Care Act provides at long last a rough blueprint for driving future commercial opportunities in the second-biggest industry sector of the world’s largest economy. With over 2,400 pages of text and a phase-in timetable that extends to 2019, it is prudent to invoke […]
Posted in Op-Ed | Also tagged , , , , , , | 3 Comments

Pharma Cheers Health Reform Legislation

Image by SEIU International via Flickr After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly. Of most importance to pharmaceutical companies, the legislation promises to significantly […]
Posted in News | Also tagged , , , , , , | 3 Comments

Tauzin’s Farewell to PhRMA

Image via Wikipedia In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our […]
Posted in People, Regulatory | Also tagged , , , , , , | 1 Comment

Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows

Image by Getty Images via Dayli Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now topping out at more than 4,000 text pages, prospects for even a basic awareness of the implications of this reform for big pharma […]
Posted in FDA, News | Also tagged , , , , , , | Leave a comment

Pharma Celebrates its Own

At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon […]
Posted in Events | Also tagged , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta